Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer
We found that for patients with metastatic prostate cancer, high levels of a protein called TK1 that is involved in cell division was linked to higher risk of death. Our findings need to be confirmed in other studies.
Authors
- Aino Siltari (ORCID: https://orcid.org/0000-0002-7814-427X)
- Teuvo L.J. Tammela (ORCID: https://orcid.org/0000-0002-3529-4649)
- Stig Linder
- Anita Csizmarik (ORCID: https://orcid.org/0000-0001-8394-3722)
- Tibor Szarvas (ORCID: https://orcid.org/0000-0002-6321-0799)
- Paavo Raittinen (ORCID: https://orcid.org/0000-0003-4207-8415)
- Gero Kramer (ORCID: https://orcid.org/0000-0003-1982-6817)
- Teemu J. Murtola (ORCID: https://orcid.org/0000-0003-2932-9590)
Institutions
- Semmelweis University (HU)
- Linköping University (SE)
- University of Helsinki (FI)
- Tampere University (FI)
- Karolinska Institutet (SE)
- Tampere University Hospital (FI)
- University of Duisburg-Essen (DE)
- Medical University of Vienna (AT)
- Aalto University (FI)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1016/j.euros.2024.10.010
- Citations
- 5
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09